Kiniksa Pharmaceuticals International, plc GAAP EPS of $0.30 beats by $0.01, revenue of $24

· seekingalpha.com

Kiniksa (KNSA) Q2 earnings: GAAP EPS beat, revenue up 55% on ARCALYST.

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.

If you have an ad-blocker enabled you may be blocked from ...


Read on WOBR AI → · More AI market news · StrategyVerse · Quant Research · WOBR.AI